Simona Vertuani

1.1k total citations
25 papers, 809 citations indexed

About

Simona Vertuani is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Simona Vertuani has authored 25 papers receiving a total of 809 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 10 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Simona Vertuani's work include Immunotherapy and Immune Responses (7 papers), Advanced Breast Cancer Therapies (4 papers) and Breast Cancer Treatment Studies (4 papers). Simona Vertuani is often cited by papers focused on Immunotherapy and Immune Responses (7 papers), Advanced Breast Cancer Therapies (4 papers) and Breast Cancer Treatment Studies (4 papers). Simona Vertuani collaborates with scholars based in Sweden, United States and Italy. Simona Vertuani's co-authors include Riccardo Gavioli, Maria G. Masucci, Årindam Majumdar, Lars Holmgren, Georg W. Bornkamm, Teresa Frisan, Rolf Kiessling, Jonas Nilsson, Per Uhlén and Yujuan Zheng and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Simona Vertuani

23 papers receiving 798 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simona Vertuani Sweden 16 392 267 208 140 92 25 809
Kaisa Auvinen Finland 17 406 1.0× 353 1.3× 236 1.1× 120 0.9× 84 0.9× 22 961
Nuran Bektas Germany 13 642 1.6× 206 0.8× 269 1.3× 56 0.4× 114 1.2× 15 1.0k
Elizabeth Maynard United States 8 503 1.3× 138 0.5× 316 1.5× 193 1.4× 59 0.6× 9 966
Annabelle M. Friera United States 13 580 1.5× 437 1.6× 312 1.5× 64 0.5× 133 1.4× 18 1.1k
Hussein Al‐Mossawi United Kingdom 17 341 0.9× 594 2.2× 278 1.3× 48 0.3× 101 1.1× 51 1.2k
Alfred Schauer Germany 14 309 0.8× 133 0.5× 213 1.0× 107 0.8× 70 0.8× 22 683
Alessandra Gentile Italy 16 618 1.6× 88 0.3× 316 1.5× 92 0.7× 77 0.8× 28 1.0k
Kazuhisa Nozawa Japan 17 268 0.7× 312 1.2× 98 0.5× 63 0.5× 58 0.6× 40 756
Hitoshi Toyoda Japan 10 432 1.1× 93 0.3× 359 1.7× 72 0.5× 99 1.1× 13 812
Yuan Mao China 20 497 1.3× 266 1.0× 445 2.1× 62 0.4× 44 0.5× 58 946

Countries citing papers authored by Simona Vertuani

Since Specialization
Citations

This map shows the geographic impact of Simona Vertuani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simona Vertuani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simona Vertuani more than expected).

Fields of papers citing papers by Simona Vertuani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simona Vertuani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simona Vertuani. The network helps show where Simona Vertuani may publish in the future.

Co-authorship network of co-authors of Simona Vertuani

This figure shows the co-authorship network connecting the top 25 collaborators of Simona Vertuani. A scholar is included among the top collaborators of Simona Vertuani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simona Vertuani. Simona Vertuani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kjellander, Christian, E Hernlund, M Ivergård, et al.. (2023). Economic burden of sickle cell disease in Sweden: a population-based national register study with 13 years follow up. DiVA at Umeå University (Umeå University). 2.
2.
Heinolainen, Krista, Silva Saarinen, Simona Vertuani, et al.. (2023). Characterization of clinicopathological features, treatment practices, and outcomes among Finnish advanced breast cancer patients in real-life clinical practice. Journal of Cancer Research and Clinical Oncology. 149(11). 9139–9149. 2 indexed citations
3.
Vertuani, Simona, et al.. (2022). Overall survival of individuals with metastatic cancer in Sweden: a nationwide study. BMC Public Health. 22(1). 1913–1913. 6 indexed citations
4.
Valachis, Antonis, et al.. (2022). Overall survival of patients with metastatic breast cancer in Sweden: a nationwide study. British Journal of Cancer. 127(4). 720–725. 25 indexed citations
5.
6.
7.
8.
Zheng, Yujuan, Simona Vertuani, Christian Gentili, et al.. (2014). AmotL2 links VE-cadherin to contractile actin fibres necessary for aortic lumen expansion. Nature Communications. 5(1). 3743–3743. 56 indexed citations
9.
Hayashi, Makoto, Årindam Majumdar, Xiujuan Li, et al.. (2013). VE-PTP regulates VEGFR2 activity in stalk cells to establish endothelial cell polarity and lumen formation. Nature Communications. 4(1). 1672–1672. 112 indexed citations
10.
Palma, Marzia, Lotta Hansson, Aniruddha Choudhury, et al.. (2011). Vaccination with dendritic cells loaded with tumor apoptotic bodies (Apo-DC) in patients with chronic lymphocytic leukemia: effects of various adjuvants and definition of immune response criteria. Cancer Immunology Immunotherapy. 61(6). 865–879. 53 indexed citations
11.
Vertuani, Simona, Claudia Curcio, Agnese Antognoli, et al.. (2010). Antibody-Dependent Natural Killer Cell–Mediated Cytotoxicity Engendered by a Kinase-Inactive Human HER2 Adenovirus-Based Vaccination Mediates Resistance to Breast Tumors. Cancer Research. 70(19). 7431–7441. 23 indexed citations
12.
Vertuani, Simona, Jehad Charo, Håkan Norell, et al.. (2008). HER-2/neu mediated down-regulation of MHC class I antigen processing prevents CTL-mediated tumor recognition upon DNA vaccination in HLA-A2 transgenic mice. Cancer Immunology Immunotherapy. 58(5). 653–664. 48 indexed citations
13.
Kiessling, Rolf, et al.. (2007). Progress in vaccination against cancer-7: report of the meeting in Stockholm, September 10–11, 2007. Cancer Immunology Immunotherapy. 57(4). 593–599.
14.
Vertuani, Simona, et al.. (2006). Retinoic acid elicits cytostatic, cytotoxic and immunomodulatory effects on uveal melanoma cells. Cancer Immunology Immunotherapy. 56(2). 193–204. 16 indexed citations
15.
Vertuani, Simona, Alessandro Sette, John Sidney, et al.. (2004). Improved Immunogenicity of an Immunodominant Epitope of the Her-2/neu Protooncogene by Alterations of MHC Contact Residues. The Journal of Immunology. 172(6). 3501–3508. 32 indexed citations
16.
Vertuani, Simona, et al.. (2003). Retinoids act as multistep modulators of the major histocompatibility class I presentation pathway and sensitize neuroblastomas to cytotoxic lymphocytes.. PubMed. 63(22). 8006–13. 28 indexed citations
17.
Vertuani, Simona, Martina Bazzaro, Fabiola Micheletti, et al.. (2002). Effect of interferon-α therapy on epitope-specific cytotoxic T lymphocyte responses in hepatitis C virus-infected individuals. European Journal of Immunology. 32(1). 144–154. 61 indexed citations
18.
Gavioli, Riccardo, Simona Vertuani, & Maria G. Masucci. (2002). Proteasome inhibitors reconstitute the presentation of cytotoxic T‐cell epitopes in Epstein‐Barr virus–associated tumors. International Journal of Cancer. 101(6). 532–538. 34 indexed citations
19.
Gavioli, Riccardo, Teresa Frisan, Simona Vertuani, Georg W. Bornkamm, & Maria G. Masucci. (2001). c-myc overexpression activates alternative pathways for intracellular proteolysis in lymphoma cells. Nature Cell Biology. 3(3). 283–288. 91 indexed citations
20.
Micheletti, Fabiola, Alessandro Canella, Simona Vertuani, et al.. (2000). Supra-Agonist Peptides Enhance the Reactivation of Memory CTL Responses. The Journal of Immunology. 165(8). 4264–4271. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kaisa Auvinen Breakdown of academic impact, for papers by Nuran Bektas Breakdown of academic impact, for papers by Elizabeth Maynard Breakdown of academic impact, for papers by Annabelle M. Friera Breakdown of academic impact, for papers by Hussein Al‐Mossawi Breakdown of academic impact, for papers by Alfred Schauer Breakdown of academic impact, for papers by Alessandra Gentile Breakdown of academic impact, for papers by Kazuhisa Nozawa Breakdown of academic impact, for papers by Hitoshi Toyoda Breakdown of academic impact, for papers by Yuan Mao
Rankless by CCL
2026